Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:36:20.658Z.
Calculation as of: 2026-10-06T16:36:20.658Z.
Quote observation: 2026-10-06T16:35:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4980e4284b6230c79d3dcd5f09fe919c7c05eb80d65ab6e095ba480293e97312
EARNINGS YIELD
N/A
Canton Strategic Holdings Inc
Market Cap
$185.09M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.12M
Earnings Yield
92.36%
TTM Avg
50.31%
3Y Avg
28.59%
5Y Avg
28.59%
Market Cap
$188.72M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$177.66M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.15M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.89M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $185.09M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.94M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | 92.36% | 50.31% | 28.59% | 28.59% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $188.72M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $177.66M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $193.74M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $174.15M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.89M | N/A | 12.15% | 12.15% | 12.15% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $171.59M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
